What is the current 10% Dextrose Injection market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the 10% Dextrose Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the 10% Dextrose Injection market?

Increasing demand for parenteral nutrition and rising prevalence of malnutrition drive the market.

What are the major challenges facing the 10% Dextrose Injection market?

Stringent regulatory requirements and competition from alternative products are key challenges.

Which regions are the leaders in the 10% Dextrose Injection market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the 10% Dextrose Injection market?

Leading companies include Baxter, Fresenius Kabi, and B. Braun Melsungen.

What are the future opportunities in the 10% Dextrose Injection market?

Emerging economies and increasing use in pediatric care offer future growth opportunities.

How does technology impact the 10% Dextrose Injection market?

Advances in infusion technology and packaging solutions enhance product safety and efficacy.

What is the current regulatory landscape for the 10% Dextrose Injection market?

Regulations vary by region, with FDA and EMA guidelines governing the US and European markets.

What is the future outlook for the 10% Dextrose Injection market?

The market is expected to experience steady growth, driven by increasing demand and innovation.

10% Dextrose Injection Growth Opportunities & Strategic Forecast 2033

10% Dextrose Injection by Application (First-Aid Treatment, Sports, Trophotherapy, Others), by Types (250 mL, 500 mL, 1000 mL), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

10% Dextrose Injection Market Size | CAGR 5.2 Forecast 2033

10% Dextrose Injection Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

10% Dextrose Injection Market Overview

The 10% Dextrose Injection market is a crucial segment of the global pharmaceutical industry, providing a vital source of energy for patients, particularly in critical care settings. As the demand for effective and efficient parenteral nutrition solutions continues to rise, the 10% Dextrose Injection market size is estimated to be approximately $1.3 billion in 2025, with a growth outlook that is expected to drive the market forecast towards significant expansion. The industry expansion is anticipated to be fueled by the increasing prevalence of malnutrition, rising healthcare expenditure, and the growing need for convenient and safe parenteral nutrition solutions, shaping the market forecast and growth outlook.

Loading chart…

The 10% Dextrose Injection market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as the rising demand for parenteral nutrition solutions, increasing healthcare expenditure, and the growing need for convenient and safe infusion therapies. Key forces shaping the industry include technological advancements in infusion devices, regulatory requirements for safety and efficacy, and competitive intensity among market players. The largest region in the 10% Dextrose Injection market is North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by the increasing demand for parenteral nutrition solutions in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B. Braun Medical Inc; ICU Medical; Baxter; Fresenius Kabi; Pfizer; Alfa Laboratories; Drugfield Pharmaceuticals Limited; Otsuka Pharmaceutical; Schwitz Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 10% Dextrose Injection market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the 10% Dextrose Injection market size and growth forecast.

Growth Drivers2 items

Increasing demand for 10% Dextrose Injection in emergency medicine and critical care settings, where it is used to treat hypoglycemia and provide essential carbohydrates to patients

Advancements in intravenous therapy and the development of new drug delivery systems, which are expected to drive the adoption of 10% Dextrose Injection in various medical applications

Restraints2 items

Stringent regulatory requirements and quality control measures, which can limit the production and distribution of 10% Dextrose Injection, thereby affecting the 10% Dextrose Injection market size

Potential side effects and complications associated with the use of 10% Dextrose Injection, such as hyperglycemia and fluid overload, which can hinder market growth

Opportunities2 items

Growing demand for 10% Dextrose Injection in developing countries, where there is a need for affordable and effective treatments for various medical conditions, driving the 10% Dextrose Injection market growth forecast

Increasing focus on personalized medicine and targeted therapies, which are expected to create new opportunities for the use of 10% Dextrose Injection in customized treatment plans

Challenges2 items

Intense competition in the 10% Dextrose Injection market, with several established players and new entrants, which can lead to pricing pressure and reduced profit margins

Need for continuous innovation and investment in research and development, to stay ahead of the competition and address emerging trends and challenges in the 10% Dextrose Injection market

Market Segmentation

Loading chart…

The Application segment of the 10% Dextrose Injection market refers to the various uses of this solution in medical settings. This includes rehydration therapy, nutrition support, and pharmacological applications. Understanding the application segment is crucial for market analysis as it contributes to the overall 10% Dextrose Injection market size. The 10% Dextrose Injection segmentation by application provides insights into the demand for this solution across different medical use cases.

The Types segment of the 10% Dextrose Injection market includes subtypes such as single-dose vials and multi-dose vials. Each subtype has its own set of characteristics, advantages, and disadvantages. For instance, single-dose vials are preferred in pediatric care due to reduced risk of contamination, while multi-dose vials are often used in adult care due to their cost-effectiveness. Analyzing the types segment is essential for understanding the market taxonomy and identifying trends in the 10% Dextrose Injection market.

10% Dextrose Injection Segmentation Breakdown9 items

Application

First-Aid Treatment

Sports

Trophotherapy

Others

Types

250 mL

500 mL

1000 mL

Regional Insights

Loading chart…

The 10% Dextrose Injection market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and also the fastest-growing region, driven by increasing adoption of 10% Dextrose Injection in healthcare settings. Key drivers for Asia Pacific include investments in healthcare infrastructure, a growing ecosystem maturity, and favorable policies supporting the use of 10% Dextrose Injection.

In North America, key drivers include a mature infrastructure, high demographics of patients requiring 10% Dextrose Injection, and significant investments in research and development. Europe is driven by a strong ecosystem maturity, favorable policies, and a high adoption rate of 10% Dextrose Injection. Latin America and Middle East & Africa are driven by growing demographics, increasing infrastructure development, and rising adoption of 10% Dextrose Injection.

The regional forecast indicates that the 10% Dextrose Injection market will experience significant growth in the coming years, driven by increasing demand for 10% Dextrose Injection in various regions. Asia Pacific is expected to dominate the market, followed by North America and Europe. The growth of the 10% Dextrose Injection market in Latin America and Middle East & Africa is expected to be driven by increasing investments in healthcare and growing demographics.

Competitive Landscape

The 10% Dextrose Injection market is moderately consolidated, with a mix of global players and local companies competing for market share. The 10% Dextrose Injection competitive landscape is driven by key competitive levers such as pricing, distribution, and product innovation. Global players focus on certifications and regulatory approvals to maintain their market position, while local companies emphasize regional partnerships and distribution networks.

Companies in the 10% Dextrose Injection market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service models, and channel strength. The following companies have adopted distinct strategic focuses:

B. Braun Medical Inc: regional expansion

ICU Medical: premium pricing

Baxter: vertical integration

Fresenius Kabi: OEM tie-ups

Pfizer: innovation pipeline

Alfa Laboratories: local manufacturing

Key 10% Dextrose Injection Companies9 items

B. Braun Medical Inc

ICU Medical

Baxter

Fresenius Kabi

Pfizer

Alfa Laboratories

Drugfield Pharmaceuticals Limited

Otsuka Pharmaceutical

Schwitz Biotech

Market Ecosystem

The 10% Dextrose Injection ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. This ecosystem is characterized by the interplay between technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. The ecosystem's boundaries are defined by the flow of goods, services, and information, from raw material suppliers to end users, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — provide dextrose and other ingredients

OEMs / manufacturers — produce 10% Dextrose Injection solutions

Distributors / channel partners — deliver products to healthcare facilities

End users / buyers — healthcare professionals and patients

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer support and maintenance services

Data/analytics providers — provide insights on market trends and usage

The flow of value within the 10% Dextrose Injection ecosystem is influenced by various control points, including regulatory approvals, standards compliance, and supply chain dependencies. The ecosystem's participants are interconnected, with each one's actions potentially impacting others. For instance, changes in regulatory requirements can affect manufacturers' production processes, while shifts in demand can impact distributors' inventory management. Moreover, the ecosystem's dynamics can vary by region, with different countries having distinct regulatory frameworks, market conditions, and healthcare systems, which can lead to differences in how value is created and captured within the 10% Dextrose Injection ecosystem.

Recent Industry Insights

The 10% Dextrose Injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing production capabilities and expanding distribution networks. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several companies have launched new products and technologies, aiming to improve the efficacy and safety of 10% Dextrose Injection solutions.

Regulatory changes have also impacted the industry, with updated guidelines on manufacturing practices and quality control. Additionally, there has been a shift in consumer and enterprise trends, with a growing emphasis on sustainable and innovative solutions. Funding rounds and expansions have supported the growth of emerging companies, driving innovation and competition in the 10% Dextrose Injection market.

Analyst Overview

As the Lead Analyst for this study, my expert view on the 10% Dextrose Injection market is that it presents a moderately attractive opportunity for investors and manufacturers. The competitive intensity is relatively high, with several established players vying for market share. However, the long-term outlook remains positive, driven by increasing demand for parenteral nutrition and the growing prevalence of malnutrition. The innovation landscape is characterized by ongoing research into new formulations and delivery systems, which is expected to drive growth in the 10% Dextrose Injection market outlook. Despite some supply chain risks, the overall demand–supply balance is expected to remain stable, with key risk factors including regulatory changes and fluctuations in raw material prices.

12 items

1. Executive Summary

2. 10% Dextrose Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 10% Dextrose Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global 10% Dextrose Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global 10% Dextrose Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global 10% Dextrose Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global 10% Dextrose Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global 10% Dextrose Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global 10% Dextrose Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global 10% Dextrose Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global 10% Dextrose Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global 10% Dextrose Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 10% Dextrose Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 10% Dextrose Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global 10% Dextrose Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global 10% Dextrose Injection Market Competition by Key Manufacturers

9.1. Global 10% Dextrose Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global 10% Dextrose Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. B. Braun Medical Inc

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ICU Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Fresenius Kabi

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Pfizer

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Alfa Laboratories

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Drugfield Pharmaceuticals Limited

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Otsuka Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Schwitz Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 10% Dextrose Injection Market

Figure 4: Global 10% Dextrose Injection Market: Drivers

Figure 5: Global 10% Dextrose Injection Market: Challenges

Figure 6: Global 10% Dextrose Injection Market: Trends

Figure 7: Global 10% Dextrose Injection Market: Opportunity

Figure 8: Global 10% Dextrose Injection Market: Restraint

Figure 9: Global 10% Dextrose Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global 10% Dextrose Injection Market Value (USD Million) By Region

Figure 19: Global 10% Dextrose Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global 10% Dextrose Injection Market Value (USD Million) By Region

Figure 27: Global 10% Dextrose Injection Market Share (%) By: Regions (2032)

Figure 28: Global 10% Dextrose Injection Market Volume (K) By Region

Figure 29: Global 10% Dextrose Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global 10% Dextrose Injection Market Value (USD Million) By Region

Figure 37: Global 10% Dextrose Injection Market Share (%) By: Regions (2032)

Figure 38: Global 10% Dextrose Injection Market Volume (K) By Region

Figure 39: Global 10% Dextrose Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global 10% Dextrose Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 10% Dextrose Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 10% Dextrose Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global 10% Dextrose Injection Market Value (USD Million) By Region

Table 14: Global 10% Dextrose Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global 10% Dextrose Injection Market Volume (K) By Region

Table 31: Global 10% Dextrose Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global 10% Dextrose Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global 10% Dextrose Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global 10% Dextrose Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: B. Braun Medical Inc Basic Information And Sales Area

Table 52: B. Braun Medical Inc. Products Portfolio

Table 53: ICU Medical Basic Information And Sales Area

Table 54: ICU Medical. Products Portfolio

Table 55: Baxter Basic Information And Sales Area

Table 56: Baxter. Products Portfolio

Table 57: Fresenius Kabi Basic Information And Sales Area

Table 58: Fresenius Kabi. Products Portfolio

Table 59: Pfizer Basic Information And Sales Area

Table 60: Pfizer. Products Portfolio

Table 61: Alfa Laboratories Basic Information And Sales Area

Table 62: Alfa Laboratories. Products Portfolio

Table 63: Drugfield Pharmaceuticals Limited Basic Information And Sales Area

Table 64: Drugfield Pharmaceuticals Limited. Products Portfolio

Table 65: Otsuka Pharmaceutical Basic Information And Sales Area

Table 66: Otsuka Pharmaceutical. Products Portfolio

Table 67: Schwitz Biotech Basic Information And Sales Area

Table 68: Schwitz Biotech. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global 10% Dextrose Injection Market Value (USD Million) By Region

Table 78: Global 10% Dextrose Injection Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global 10% Dextrose Injection Market Volume (K) By Region

Table 95: Global 10% Dextrose Injection Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

10% Dextrose Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B. Braun Medical Inc; ICU Medical; Baxter; Fresenius Kabi; Pfizer; Alfa Laboratories; Drugfield Pharmaceuticals Limited; Otsuka Pharmaceutical; Schwitz Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options